The Combination Vaccine against Measles
https://doi.org/10.31631/2073-3046-2020-19-4-57-62
Abstract
Relevance. Measles is one of the most contagious infectious viral diseases affecting all age groups and leading to severe complications. There is no specific therapy for measles, but highly effective vaccines are available for specific prevention, both in monoform and in combination. The world is currently experiencing a significant rise in the incidence of measles, which dictates the need to increase coverage with preventive vaccinations. Aims. Show the necessity of using combined drugs for the prevention of measles, rubella, and mumps in non-standard clinical situations and in pregravid preparation. Conclusions. All currently used vaccines, regardless of strain composition, are capable of providing effective protection against wild variants of the measles virus. Combined drugs against measles, rubella, and mumps, have proven their safety and effectiveness for many years of use in the world, including in Russia, and can be used without restrictions. Combined vaccination against measles, rubella, and mumps should be considered as a mandatory measure for additional immunization of citizens who do not have information about revaccination or acceptable confirmation of the immune status, especially as a mandatory element of pre-conceptional preparation of women of childbearing age.
About the Author
M. P. Kostinov
I.I. Mechnikov Research Institute of Vaccines and Sera;
First Moscow State Medical University named by I. M. Sechenov (Sechenov University)
Russian Federation
Russian Federation
Michail P. Kostinov – Dr. Sci. (Med.), professor, Head of the laboratory of Vaccination and Immunotherapy of Allergic Diseases
5А Maly Kazenny pereulok, Moscow, 105064;
professor of the Department of Epidemiology and Modern Immunization Technology
+7 (495-)917-41-49
References
1. Measles. Key Facts. WHO. https://www.who.int/ru/news-room/fact-sheets/detail/measles. Accessed 24.01.2019.
2. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiyskoy Federacii v 2018 godu: Gosudarsvenniy doklad. Moscow. Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. 2019:254.
3. Kostinov MP, Filatov NN, Zhuravlev PI, et al. Age-related immune response to measles virus in staff of a large city hospital. Russian Pulmonology. 2018;28(6):701–707 (In Russ.). https://doi.org/10.18093/0869-0189-2018-28-6-701-707].
4. Federalnoe rukovodstvo po ispolzovaniyu lekarstvennyih sredstv (formulyarnaya sistema, spravochnoe izdanie). Ed.: AG Chuchalin, VV Yasnetsov. Moscow. 2016: 745–768 (In Russ.).
5. Haitov RM, Ilina NI. Allergologiya i immunologiya. Natsionalnoe rukovodstvo. Moscow.«GEOTAR-Media». 2014:656 (In Russ.).
6. Kostinov MP, Lavrov VF. Vaktsinyi novogo pokoleniya v 2-e izd. dopol. Moscow. MDV.2010:192 (In Russ.).
7. Zverev VV, Haitov RM. Vaktsinyi i vaktsinatsiya. Natsionalnoe rukovodstvo. Kratkoe izd. Moscow. «GEOTAR-Media». 2014:640 (In Russ.).
8. Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec. 2017 Apr 28;92(17):205–27.
9. Hendriks J, MSc, Blume S. Measles Vaccination before the measles-mumps-rubella vaccine. Am J Public Health. 2013;103(8):1393–1.
10. Duclos P, Ward BJ. Measles vaccines: a review of adverse events. Drug Saf. 1998 Dec;19(6):435–54.
11. Bonnet MC, Dutta A, Weinberger C, Plotkin SA. Mumps vaccine virus strains and aseptic meningitis. Vaccine. 2006 Nov 30;24(49–50):7037–45.
12. Rubin S, Plotkin S. Mumps Vaccine. In: Plotkin S, Orenstein W, Offit PA. Vaccines 6th ed. Philadelphia: Saunders, 2013:419–46.
13. Kostinov MP, Zverev VV. Vaktsinatsiya protiv gepatita В, grippa i krasnuhi vzroslyih patsientov s hronicheskimi zabolevaniyami Moscow. MDV, 2009:196 (In Russ.).
14. Vaktsinatsiya detey s narushennyim sostoyaniem zdorovya. Ed.: MP Kostinov. Moscow. Mpress. 2013: 432 (In Russ.).
15. Snegova N.F., Kostinov M.P., Pakhomov D.V., Ilina N.I. Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects). Russian Journal of Infection and Immunity. 2019;9(2):325–336. (In Russ.) https://doi.org/10.15789/2220-7619-2019-2-325-336 (In Russ.).
16. Polischuk VB, Ryzhov AA., Kostinov MP, et al. Condition of Anti-Measles Immunity in Patients on Waiting-List for Lung Transplantation. Journal of microbiology, epidemiology and immunobiology. 2016;(4):55–60. (In Russ.). https://doi.org/10.36233/0372-9311-2016-4-55-60.
17. Respiratornaya meditsina: rukovodstvo v 3 tomah. Ed.: A.G. Chuchalin, Moscow. «Littera»; 2017 (In Russ.).
18. Kostinov M.P. Vaktsinatsiya detey s zabolevaniyami pochek: Posobie dlya vrachey. Moscow. 2012:95 (In Russ.).
19. Vaktsinatsiya vzroslyih s bronholegochnoy patologiey: Rukovodstvo dlya vrachey. Ed.: MP Kostinova. MoscowArt studiya «Sozvezdie», 2013:109 (In Russ.).
20. Balabolkin II, Kostinov MP, Ignateva GV, et al.. Immunoprofilaktika zhivoy korevoy vaktsinoy detey s allergicheskimi zabolevaniyami. Metodicheskie rekomendatsii. Moscow 1987:6 (In Russ.).
21. Kostinov MP, Balabolkin II, Igna’teva GV, Sadykova DK. Characteristics of the clinical course of the post-vaccination period and the development of nti-measles immunity in children with allergic diseases. Pediatriia. 1989;(9):33–8 (In Russ.).
22. Kostinov MP, Gervazieva VB, Balabolkin II. Immunologic reactivity of children with allergic diseases during the measles vaccinal process. Zh Mikrobiol Epidemiol Immunobiol. 1990 Mar;(3):81–5 (In Russ.).
23. Soloveva IL, Lezhen EM, Kuselman AI, et al. Vaccination of ailing children with home-made measles and parotitis vaccine. Ulyanovskiy mediko-biologicheskiy zhurnal. 2013;2:20–25 (In Russ.).
24. Kostinov MP, Balabolkin II, Gervazieva VB, Ovsyannikova IG. Znachenie issledovaniya obschego immunoglobulina E pri immunizatsii zhivoy korevoy vaktsinoy detey s allergicheskimi zabolevaniyami. Immunologiya. 1990;1:41–44](In Russ.).
25. Kliniko-immunologicheskaya effektivnost immunobiologicheskih preparatov. Spravochnik. Ed.: Kostinov MP, Ozeretskovskiy NA., Moscow. «Miklosh», 2004:256 (In Russ.).
26. Ibragimova EM, Yuminova NV, Kostinov MP, et al. Nekotoryie aspektyi izucheniya populyatsionnogo immuniteta k kori, epidemicheskomu parotitu i krasnuhe na territorii Primorskogo kraya. Epidemiology and Vaccinal Prevention. 2005;3(23):21–23 (In Russ.).
27. Kostinov M.P., Kovalchuk N.V., Nevmyanov Sh.A., et al. Encepur® children: a vaccine for prevention of tick-borne encephalitis in children. new safety and immunogenicity data. Epidemiology and Vaccinal Prevention. 2009;3(46):43–50 (In Russ.).
28. Костинов М.П., Шмитько А.Д., Соловьева И.Л., и др. Защищены ли от кори дети с аллергическими заболеваниями и часто болеющие после ревакцинации. Педиатрия. 2017; 96(4):140-145 [Kostinov M.P., Shmitko A.D., Soloveva I.L., et al. Are children with allergic diseases and sickly children resistant to measles after revaccination? Pediatria. 2017; 96(4):140–145. (In Russ.).
29. Kostinov MP, Shmitko AD, Solovieva IL, et al. Is a third dose of measles vaccine necessary – an immunologist’s view. Journal of microbiology, epidemiology and immunobiology. 2016;(5):88–94 (In Russ.). https://doi.org/10.36233/0372-9311-2016-5-88-94 (In Russ.).
30. Cherdantsev AP, Kostinov M.P., Kuselman A.I. Vaktsinatsiya beremennyih protiv grippa i drugih infektsionnyih zabolevaniy: Rukovodstvo dlya vrachey. Moscow. Gruppa MDV.2018:143 (In Russ.).
31. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recom Rep. 2013;62(RR-04):1–34.
Review
For citations:
Kostinov M.P. The Combination Vaccine against Measles. Epidemiology and Vaccinal Prevention. 2020;19(4):57-62. (In Russ.) https://doi.org/10.31631/2073-3046-2020-19-4-57-62
Views:
1413
Email this article 